Springer Singapore, Singapore, pp 71100
Personalized Risk Assessment with PlexusDx Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways
The first is that semaglutide is semaglutide the molecule that produced about 15% mean weight loss in STEP 1 (Wilding et al., 2021), that reduced food-cue reward signalling in van Bloemendaal's imaging (van Bloemendaal et al., 2014), that the broader incretin literature has characterised in detail (Drucker, 2018), does not become a different molecule because of where it was synthesised
Insurance may reimburse patients for branded medications, though MEDVi itself operates as a cash-pay service without direct insurance billing
Cagrilintide is a synthetic peptide supplied as a lyophilised (freeze-dried) powder for laboratory and in-vitro research purposes only
To provide a clearer picture, heres a quick-reference table summarizing the key properties of each component in the blend